@Oakely_Dokely Stroke & COVID https://t.co/whJ1TlG4a9
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | As fatalities continue to rise, elucidation of…
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | As fatalities continue to rise, elucidation of…
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | As fatalities continue to rise, elucidation of…
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | As fatalities continue to rise, elucidation of…
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | As fatalities continue to rise, elucidation of…
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | Why is there a disproportionate rate among blac…
RT @JNNP_BMJ: High mortality rate in COVID-19–associated stroke, analysis of risk factors | Why is there a disproportionate rate among blac…
High mortality rate in COVID-19–associated stroke, analysis of risk factors | Why is there a disproportionate rate among black patients? #stroke #covid #BAME https://t.co/H72UT7j6SA
RT @AdamDmytriw: Analysis of our work in NAN-C by a world neuroendovascular expert in one of the hardest-hit countries. Privileged to be th…
RT @AdamDmytriw: Analysis of our work in NAN-C by a world neuroendovascular expert in one of the hardest-hit countries. Privileged to be th…
Way to go, @AdamDmytriw !
Analysis of our work in NAN-C by a world neuroendovascular expert in one of the hardest-hit countries. Privileged to be the Canadian lead of this consortium. High mortality rate in COVID-19–associated stroke, analysis of risk factors: https://t.co/0mRVWW
High mortality rate in COVID-19-associated stroke, analysis of risk factors https://t.co/hWhPSwZ3H4